Proteomics International Laboratories (ASX:PIQ) Total Equity : A$5.23 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Proteomics International Laboratories Total Equity?

Proteomics International Laboratories's total equity for the quarter that ended in Dec. 2023 was A$5.23 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Proteomics International Laboratories Total Equity Historical Data

The historical data trend for Proteomics International Laboratories's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteomics International Laboratories Total Equity Chart

Proteomics International Laboratories Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Equity

Get a 7-Day Free Trial

2.99

4.44

7.61

3.39

8.32

Proteomics International Laboratories Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Equity	Get a 7-Day Free Trial													4.85	3.39	7.15	8.32	5.23

Proteomics International Laboratories Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Proteomics International Laboratories's Total Equity for the fiscal year that ended in Jun. 2023 is calculated as

Total Equity	=	Total Assets(Q: Jun. 2023 )	-	Total Liabilities(Q: Jun. 2023 )
	=	10.075	-	1.752
	=	8.32

Proteomics International Laboratories's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	6.946	-	1.717
	=	5.23

Proteomics International Laboratories Total Equity Related Terms

Thank you for viewing the detailed overview of Proteomics International Laboratories's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Proteomics International Laboratories (ASX:PIQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Proteomics International Laboratories Ltd (ASX:PIQ) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009

Website

https://www.proteomics.com.au

Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial-scale study of the structure and function of proteins. Its operations are divided into PromarkerD which targets the diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.

Proteomics International Laboratories (ASX:PIQ) Headlines

No Headlines